Gilead Sciences, Inc.

Gilead Sciences, Inc. - ROEverified

GILD

Price:

$150.11

Market Cap:

$186.37B

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vo...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1992-01-22

Stock Exchange

NASDAQ

Ticker

GILD

The ROE as of September 2026 (TTM) for Gilead Sciences, Inc. (GILD) is -16.28%

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -16.28%. This represents a change of 15.58% compared to the average of -14.09% of the last 4 quarters.

Gilead Sciences, Inc. (GILD) Historical ROE (quarterly & annually)

How has GILD ROE performed in the past?

The mean historical ROE of Gilead Sciences, Inc. over the last ten years is 26.02%. The current -16.28% ROE has changed -162.59% with respect to the historical average. Over the past ten years (40 quarters), GILD's ROE was at its highest in in the September 2016 quarter at 19.74%. The ROE was at its lowest in in the June 2026 quarter at -88.74%.

Quarterly (TTM)
Annual

Average

26.02%

Median

24.36%

Minimum

0.68%

Maximum

71.48%

Gilead Sciences, Inc. (GILD) ROE by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.27%

Maximum Annual ROE = 71.48%

Minimum Annual Increase = -97.17%

Minimum Annual ROE = 0.68%

Quarterly (TTM)
Annual
YearROEChange
202537.49%1.41%
20242.48%-89.99%
202324.81%14.76%
202221.62%-26.83%
202129.55%4.27%
20200.68%-97.17%
201923.91%-6.25%
201825.51%12.66%
201722.64%-68.33%
201671.48%-26.84%

Gilead Sciences, Inc. (GILD) Average ROE

How has GILD ROE performed in the past?

The current ROE of Gilead Sciences, Inc. (GILD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.59%

5-year avg

23.19%

10-year avg

26.02%

Gilead Sciences, Inc. (GILD) ROE vs. Peers

How is GILD’s ROE compared to its peers?

Gilead Sciences, Inc.’s ROE is less than Pfizer Inc. (4.89%), less than Amgen Inc. (89.32%), less than Sanofi (5.52%), less than Bristol-Myers Squibb Company (46.75%), less than GSK plc (28.35%), less than Merck & Co., Inc. (6.60%), less than Danaher Corporation (7.66%), less than Boston Scientific Corporation (14.90%), less than Novo Nordisk A/S (59.09%), less than Stryker Corporation (16.36%),

CompanyROEMarket cap
4.89%$157.30B
89.32%$208.14B
5.52%$102.00B
46.75%$128.81B
28.35%$100.62B
6.60%$362.47B
7.66%$148.87B
14.90%$64.42B
59.09%$192.01B
16.36%$105.47B

Build a custom stock screener for Gilead Sciences, Inc. (GILD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GILD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Gilead Sciences, Inc.'s ROE?

How is the ROE calculated for Gilead Sciences, Inc. (GILD)?

What is the highest ROE for Gilead Sciences, Inc. (GILD)?

What is the 3-year average ROE for Gilead Sciences, Inc. (GILD)?

What is the 5-year average ROE for Gilead Sciences, Inc. (GILD)?

How does the current ROE for Gilead Sciences, Inc. (GILD) compare to its historical average?